Clinical Trial Update: A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green [EARLY_Phase 1]

View source ↗

Summary

Update on an early-phase pilot trial evaluating optical molecular imaging with indocyanine green to guide percutaneous biopsy of hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hepatocellular Carcinoma | EARLY_Phase 1 | Status: COMPLETED